Kyverna Therapeutics, Inc.
USD9.13
+0.35 (+3.99%)
CEO
Warner Biddle
IPO Date
2024-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.78
Prev. Close
$8.78
Day Low
$8.65
Day High
$9.19
52W Low
$2.52
52W High
$13.67
Market Cap
$0.40B
Volume
0.38M
| 20,582 |
| $8.59 |
| 29 May 2026 | Cohen Fred E | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | Cohen Fred E | director | A-Award | Acquired | 20,582 | $8.59 |
| 29 May 2026 | SEIDENBERG BETH C | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | SEIDENBERG BETH C | director | A-Award | Acquired | 20,582 | $8.59 |
| 29 May 2026 | Shaw Christi | director, officer: Executive Chairperson | F-InKind | Disposed | 4,194 | $8.59 |
| 29 May 2026 | Aktar Mert | director | A-Award | Acquired | 5,093 | $0.00 |
| 29 May 2026 | Aktar Mert | director | A-Award | Acquired | 20,582 | $8.59 |
| 20 May 2026 | Martini Gregory S. | Chief Financial Officer | A-Award | Acquired | 325,000 | $8.54 |